For patients with thyroid eye disease, teprotumumab was found to decrease the inflammation in the eye and the build-up of tissues behind the eye that produce the long-term symptoms that reduce quality of life, stated study.
from Medindia Health News https://ift.tt/2Js05tt
No comments
Post a Comment
Thanks for comment via will connect you within 24 hours.